In a nationwide prospective cohort study, researchers evaluated the independent and joint effects of sleep and liver function biomarkers on liver cancer.
Gilead Sciences, Inc. today announced new research to be presented at The Liver Meeting® 2024, hosted by the American Association for the Study of Liver Diseases (AASLD) from November 15-19 in San ...